2. NF-κB MAPK/ERK Pathway
  3. RANKL/RANK p38 MAPK NF-κB
  4. Anti-osteoporosis agent-8

Anti-osteoporosis agent-8 (Compound 4aa) is an inhibitor for RANKL, which inhibits RANKL-induced osteoclastogenesis and osteoclast differentiation (IC50 is 2.41 μM) in cells RAW264.7. Anti-osteoporosis agent-8 ameliorates bone loss in an ovariectomized (OVX) mice model.

For research use only. We do not sell to patients.

Anti-osteoporosis agent-8 Chemical Structure

Anti-osteoporosis agent-8 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  
Synthetic products have potential research and development risk.

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Anti-osteoporosis agent-8 Related Antibodies

Top Publications Citing Use of Products

View All p38 MAPK Isoform Specific Products:

View All Isoforms
p38 MAPK p38α p38β MAPK13 p38δ p38γ

View All NF-κB Isoform Specific Products:

View All Isoforms
NF-κB NF-κB1/p50 RelA/p65 RelB c-Rel

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Anti-osteoporosis agent-8 (Compound 4aa) is an inhibitor for RANKL, which inhibits RANKL-induced osteoclastogenesis and osteoclast differentiation (IC50 is 2.41 μM) in cells RAW264.7. Anti-osteoporosis agent-8 ameliorates bone loss in an ovariectomized (OVX) mice model[1].

In Vitro

Anti-osteoporosis agent-8 (0-10 μM, 5 days) promotes osteoblast differentiation in cells MC3T3-E1 through activation of BMP2 signaling pathway[1].
Anti-osteoporosis agent-8 (5 μM, 6 h) inhibits the osteoclast-related genes expression, osteoclastogenesis, and osteoclastic bone resorption, though inhibition of MAPK and NF-κB-signaling pathway[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Anti-osteoporosis agent-8 Related Antibodies

Western Blot Analysis[1]

Cell Line: BMMS
Concentration: 5 μM
Incubation Time: 6 h
Result: Inhibited phosphorylation of p38, ERK, JNK, p65 and IκBα.

Real Time qPCR[1]

Cell Line: MC3T3-E1
Concentration: 0-10 μM
Incubation Time: 5 days
Result: Promoted expression of BMP2, Runx2 and Smad.
In Vivo

Anti-osteoporosis agent-8 (10 mg/kg, i.p., every 2 days for 8 weeks) prevents the ovariectomization induced bone loss in C57BL/6 mice model[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: ovariectomized C57BL/6 mice model[1]
Dosage: 10 mg/kg
Administration: i.p., every other days, for 8 weeks
Result: Reduced the bone loss, increased bone volume/total bone volume, trabecular thickness and trabecular number, without significant toxicity in mainly organs.
Molecular Weight

431.31

Formula

C18H19F3N2O2Se
SMILES

O=C(NC1=CC=CN=C1)[C@H]([Se]C2=CC=CC=C2)C(C)(OCC(F)(F)F)C
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Anti-osteoporosis agent-8 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Anti-osteoporosis agent-8RANKL/RANKp38 MAPKNF-κBNuclear factor-κBNuclear factor-kappaBRAW264.7C57BL/6 miceMC3T3-E1BMMSInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Anti-osteoporosis agent-8
Cat. No.:
HY-158311
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

Request for HNMR Report

We have received your request and will respond to you as soon as possible.